After over six months of consultation with the eating disorders community and wider health sector, NEDC has published a consultation report which outlines our findings.
Read more
NEDC e-Bulletin Editor’s Note Welcome to the 60th edition of the NEDC e-Bulletin.
Read more
Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more
Editor’s Note Introduction of new NEDC body image fact sheet Associate Professor Rachel F.
Read more
